Clinical Trial Update: Human Papilloma Virus (HPV) Vaccine Immunogenicity and Safety Trial in Young and Adult Women With GSK Biologicals' HPV-16/18 [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating immunogenicity and safety of HPV-16/18 vaccine in young and adult women; study completed with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Papillomavirus Infections

Drugs mentioned

• HPV-16/18 vaccine (Cervarix)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Papillomavirus | Phase 3 | Status: COMPLETED | Results posted: 2010-08-06